[1] |
王上. AGGF1蛋白对血管损伤治疗机制的研究[D]. 武汉: 华中科技大学, 2019.
|
[2] |
胡振坤. 血管生长因子AGGF1抑制血管损伤后新生内膜的形成及机制[D]. 武汉: 华中科技大学, 2017.
|
[3] |
YAO Y, HU Z, YE J, et al. Targeting AGGF1(angiogenic factor with G patch and FHA domains 1)for blocking neointimal formation after vascular injury[J]. J Am Heart Assoc, 2017, 6(6):e005889.
|
[4] |
Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature[J]. Circulation, 1979, 59(3):607-609.
|
[5] |
LIU J, LIU Y, JIA K, et al. Clinical analysis of lectin-like oxidized low-density lipoprotein receptor-1 in patients with in-stent restenosis after percutaneous coronary intervention[J]. Medicine(Baltimore), 2018, 97(17):e0366.
|
[6] |
TIMUR A A, DRISCOLL D J, WANG Q. Biomedicine and diseases:the Klippel-Trenaunay syndrome,vascular anomalies and vascular morphogenesis[J]. Cell Mol Life Sci, 2005, 62(13):1434-1447.
|
[7] |
姚雨峰. 血管生长因子AGGF1通过激活自噬促进血管新生治疗缺血性心脏病[D]. 武汉: 华中科技大学, 2016.
|
[8] |
ZHU Q, ENKHJARGAL B, HUANG L, et al. Aggf1 attenuates neuroinflammation and BBB disruption via PI3K/Akt/NF-κB pathway after subarachnoid hemorrhage in rats[J]. J Neuroinflammation, 2018, 15(1):178.
|
[9] |
LIU Y, SUN J, MA X, et al. Vaccarin regulates diabetic chronic wound healing through FOXP2/AGGF1 pathways[J]. Int J Mol Sci, 2020, 21(6):1966.
|
[10] |
刘军锋, 敬锐, 刘雅宁, 等. 单核细胞 LOX-1、CX3CR1表达与冠状动脉近段/中段狭窄的关系[J]. 检验医学, 2017, 32(11):1024-1030.
DOI
|
[11] |
HU F Y, WU C, LI Y, et al. AGGF1 is a novel anti-inflammatory factor associated with TNF-α-induced endothelial activation[J]. Cell Signal, 2013, 25(8):1645-1653.
|
[12] |
吴翀. 血管新生因子AGGF1调节内皮细胞功能及与汉族人群冠心病关联研究[D]. 北京: 北京大学, 2013.
|
[13] |
孙茹, 付文波. 非阻塞性缺血性冠状动脉疾病的研究进展[J]. 临床内科杂志, 2022, 39(7):499-502.
|